Related Experiment Video
Updated: Aug 11, 2026
07:35
Gene Transfer for Ischemic Heart Failure in a Preclinical Model
Published on: May 15, 2011
Gene therapy for cardiovascular disease: a case for cautious optimism
R Khurana1, J F Martin, I Zachary
1Center for Cardiovascular Biology and Medicine, Department of Medicine, University College London, London, United Kingdom.
Hypertension (Dallas, Tex. : 1979)
|November 17, 2001
Summary
Gene therapy shows promise for cardiovascular diseases like ischemic heart disease and hypertension. Further research in gene transfer and target identification is needed to realize its full therapeutic potential.
Area of Science:
- Cardiovascular Medicine
- Molecular Biology
- Genetics
Background:
- Gene therapy is a rapidly developing field for cardiovascular disease treatment.
- Therapeutic angiogenesis using vascular endothelial growth factor (VEGF) shows promise for ischemic heart disease.
- VEGF also aids in preventing postangioplasty restenosis and graft arteriopathy by enhancing endothelial functions.
Purpose of the Study:
- To explore the potential of gene therapy in treating various cardiovascular conditions.
- To identify novel gene targets for cardiovascular diseases like atherosclerosis and hypertension.
- To review current advancements and future prospects of cardiovascular gene therapy.
Main Methods:
- Gene transfer of angiogenic cytokines (VEGF, FGF).
- Gene transfer of endothelial NO synthase (eNOS), PGI synthase, cell cycle regulators, and antisense oligonucleotides.
- Targeting the renin-angiotensin system for antihypertensive strategies.
Main Results:
- VEGF promotes endothelial regeneration and inhibits smooth muscle cell proliferation.
- Gene transfer of eNOS, PGI synthase, and cell cycle regulators can inhibit neointimal hyperplasia.
- Gene therapy approaches show potential in animal models for hypertension and inherited cardiovascular defects.
Conclusions:
- Cardiovascular gene therapy holds significant future potential but is in its early stages.
- Further advancements in gene transfer vectors and target gene identification are crucial.
- Gene therapy offers a promising avenue for treating complex cardiovascular pathologies.
Related Concept Videos
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...